ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Dominick J. Angiolillo, Deepak L. Bhatt, Christopher P. Cannon, John W. Eikelboom, C. Michael Gibson, Shaun G. Goodman, Christopher B. Granger, David R. Holmes, Renato D. Lopes, Roxana Mehran, David J. Moliterno

A growing number of patients undergoing PCI with stent implantation also have atrial fibrillation, necessitating careful management of antithrombotic therapy. This document updates the 2018 recommendations based on recent clinical trials and consensus statements. It emphasizes the need for oral anticoagulation to prevent thromboembolism and dual antiplatelet therapy to prevent coronary complications, while also addressing the increased risk of bleeding associated with these treatments.